Skip to main content

Table 1 Baseline characteristics of the study collective

From: Left atrial appendage morphology, echocardiographic characterization, procedural data and in-hospital outcome of patients receiving left atrial appendage occlusion device implantation: a prospective observational study

  Watchman ACP 2 All p Value
Patients, n (%) 22 (59.5) 15 (40.5) 37 (100) -
Male, n (%) 16 (72.7) 9 (60) 25 (67.6) 0.417
Age, y (IQR) 77 (70.75–81) 80 (76–83) 79 (71.5–81.5) 0.213
Height, cm (IQR) 170 (167.75–177) 170 (165–172) 170 (167–175) 0.090
Weight, kg (IQR) 80.5 (67.5–90) 83.5 (69.75–93.25) 81.5 (69.25–90) 0.531
Reason for not taking OAC, n (%)     
 - GI bleeding 8 (36.4) 8 (53.8) 16 (43.2) 0.306
 - ICB 4 (18.2) 2 (13.3) 6 (16.2) 0.694
 - Muscle bleeding 2 (9.1) 0 (0) 2 (5.4) 0.230
 - Other bleeding localization 2 (9.1) 3 (20) 5 (13.5) 0.341
 - Refusal 3 (13.6) 0 (0) 3 (8.1) 0.136
 - Other causes 3 (13.6) 2 (13.3) 5 (13.5) 1.000
AF type, n (%)     
 - Paroxysmal 12 (54.5) 7 (46.7) 19 (51.4) 0.638
 - Persistent 2 (9.1) 3 (20) 5 (13.5) 0.341
 - Permanent 8 (36.4) 5 (33.3) 13 (35.1) 0.850
Heart rhythm at hospitalization, n (%)     
 - SR 6 (27.3) 6 (40) 12 (32.4) 0.225
 - AF 12 (54.5) 9 (60) 21 (56.8) 0.742
 - PM 2 (9.1) 0 (0) 2 (5.4) 0.230
 - unsp. 2 (9.1) 0 (0) 2 (5.4) 0.230
Prior PVI, n (%) 2 (9.1) 1 (6.7) 3 (8.1) 0.791
Hypertension, n (%) 21 (95.5) 15 (100) 36 (97.3) 0.403
Diabetes mellitus, n (%) 6 (27.3) 6 (40) 12 (32.4) 0.417
TIA, n (%) 4 (18.2) 0 (0) 4 (10.8) 0.080
Stroke, n (%) 1 (4.5) 2 (13.3) 3 (8.11) 0.336
Coronary artery disease, n (%) 13 (59.1) 8 (53.3) 21 (56.8) 0.729
Peripheral vascular disease, n (%) 3 (13.6) 1 (6.7) 4 (10.8) 0.503
Renal failure, n (%) 8 (36.4) 5 (33.3) 13 (35.1) 0.850
 - GFR (IQR) 70 (43.5–70) 70 (41–70) 70 (42–70) 0.636
Liver failure, n (%) 3 (13.6) 1 (6.7) 4 (10.8) 0.503
Prior bleeding, n (%) 16 (72.7) 13 (86.7) 29 (78.4) 0.312
Labile INR, n (%) 2 (9.1) 1 (6.7) 3 (8.1) 0.791
CHA2DS2-VASc score (IQR) 4 (3–5) 5 (3–5) 5 (3–5) 0.292
HAS-BLED score (IQR) 4 (3–5) 4 (3–4) 4 (3–5) 0.538
Baseline OAC, n (%)     
 - None 10 (45.5) 9 (60) 19 (51.4) 0.385
 - Warfarin 3 (13.6) 3 (20) 6 (16.2) 0.606
 - Rivaroxaban 6 (27.3) 2 (13.3) 8 (21.6) 0.312
 - Dabigatran 1 (4.5) 1 (6.7) 2 (5.4) 0.779
 - Apixaban 2 (9.1) 0 (0) 2 (5.4) 0.230
Cardiac device, n (%)     
 - PM 4 (18.2) 3 (20) 7 (18.9) 0.890
 - ICD 1 (4.5) 2 (13.3) 3 (8.1) 0.336
  1. Values are given as medians (25th and 75th percentiles) or total numbers (percentage). AF atrial fibrillation, GFR glomerular filtration rate, GI gastrointestinal, ICB intracerebral bleeding, ICD implantable cardioverter defibrillator, INR international normalized ratio, OAC oral anticoagulation, PM pacemaker, PVI pulmonary vein isolation, SR sinus rhythm, TIA transient ischemic attack, unsp. unspecified